Source link : https://newshealth.biz/health-news/newer-diabetes-drugs-including-glp-1-agonists-tied-to-autoimmunity-risk/
Little previous research has examined immunological effects of newer antidiabetic agents including DPP-4 inhibitors, GLP-1 receptor agonists, and SGLT-2 inhibitors. This study analyzed a large medical records database to look for associations between these drug classes and new diagnoses of various autoimmune conditions. No differences in autoimmune disease rates were seen between GLP-1 drugs and […]
The post Newer Diabetes Drugs, Including GLP-1 Agonists, Tied to Autoimmunity Risk first appeared on News Health.
—-
Author : News Health
Publish date : 2026-07-09 21:34:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8